Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed No phase listed Observational Accepts healthy volunteers

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

ClinicalTrials.gov ID: NCT00914758

Public ClinicalTrials.gov record NCT00914758. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparison of Alemtuzumab (Campath®) and High Dose Interferon Beta-1a (Rebif®) Treatment on Cognition in Subjects With Relapsing Forms of MS

Study identification

NCT ID
NCT00914758
Recruitment status
Not listed
Study type
Observational
Phase
Not listed
Lead sponsor
Washington Neuropsychology Research Group
Other
Enrollment
1 participant

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
25 Years to 50 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2009
Primary completion
Sep 30, 2011
Completion
Nov 30, 2011
Last update posted
Jun 4, 2009

2009 – 2011

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
The Research and Education Institute of Alta Bates Summit Medical Center Berkely California 94705
Associates In Neurology. PSC Lexington Kentucky 40513
Springfield Neurology Associates, LLC Springfield Massachusetts 01104
Dartmouth Medical School/Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Multiple Sclerosis Center of NE New York, Empire Neurology, PC Latham New York 12110
Multiple Sclerosis Center, University of Rochester Medical Center Rochester New York 14642
MS Center of Greater Washington Vienna Virginia 22180

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00914758, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2009 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00914758 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →